Assyro AI

Orange Book product · Brand (NDA)

MULTIHANCE

GADOBENATE DIMEGLUMINE

Brand (NDA)NDA 021357RX BRACCO

At a glance

Nov 23, 2004

Approved

Brand (NDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 23, 2004

    21 yr 11 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

GADOBENATE DIMEGLUMINE

Strength

2.645GM/5ML (529MG/ML)

Dosage form

INJECTABLE

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 021357

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.